204 related articles for article (PubMed ID: 28710254)
1. The Plasticity and Stability of Regulatory T Cells during Viral-Induced Inflammatory Lesions.
Bhela S; Varanasi SK; Jaggi U; Sloan SS; Rajasagi NK; Rouse BT
J Immunol; 2017 Aug; 199(4):1342-1352. PubMed ID: 28710254
[TBL] [Abstract][Full Text] [Related]
2. In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions.
Sehrawat S; Suvas S; Sarangi PP; Suryawanshi A; Rouse BT
J Virol; 2008 Jul; 82(14):6838-51. PubMed ID: 18480441
[TBL] [Abstract][Full Text] [Related]
3. IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.
Gaddipati S; Estrada K; Rao P; Jerome AD; Suvas S
J Immunol; 2015 Jan; 194(1):273-82. PubMed ID: 25411200
[TBL] [Abstract][Full Text] [Related]
4. Azacytidine Treatment Inhibits the Progression of Herpes Stromal Keratitis by Enhancing Regulatory T Cell Function.
Varanasi SK; Reddy PBJ; Bhela S; Jaggi U; Gimenez F; Rouse BT
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100624
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions.
Suvas S; Azkur AK; Kim BS; Kumaraguru U; Rouse BT
J Immunol; 2004 Apr; 172(7):4123-32. PubMed ID: 15034024
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators.
Sehrawat S; Rouse BT
J Immunol; 2008 Jun; 180(11):7636-47. PubMed ID: 18490766
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
[TBL] [Abstract][Full Text] [Related]
8. On the role of regulatory T cells during viral-induced inflammatory lesions.
Veiga-Parga T; Suryawanshi A; Mulik S; Giménez F; Sharma S; Sparwasser T; Rouse BT
J Immunol; 2012 Dec; 189(12):5924-33. PubMed ID: 23129753
[TBL] [Abstract][Full Text] [Related]
9. Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model.
Kasahara H; Kondo T; Nakatsukasa H; Chikuma S; Ito M; Ando M; Kurebayashi Y; Sekiya T; Yamada T; Okamoto S; Yoshimura A
Int Immunol; 2017 Dec; 29(10):457-469. PubMed ID: 29126272
[TBL] [Abstract][Full Text] [Related]
10. On the role of retinoic acid in virus induced inflammatory response in cornea.
Jaggi U; Varanasi SK; Bhela S; Rouse BT
Microbes Infect; 2018; 20(6):337-345. PubMed ID: 29842984
[TBL] [Abstract][Full Text] [Related]
11. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling.
Veiga-Parga T; Suryawanshi A; Rouse BT
PLoS Pathog; 2011 Dec; 7(12):e1002427. PubMed ID: 22174686
[TBL] [Abstract][Full Text] [Related]
12. Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis.
Banerjee K; Biswas PS; Rouse BT
J Interferon Cytokine Res; 2007 Jan; 27(1):65-75. PubMed ID: 17266445
[TBL] [Abstract][Full Text] [Related]
13. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions.
Gangappa S; Deshpande SP; Rouse BT
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):453-9. PubMed ID: 10670475
[TBL] [Abstract][Full Text] [Related]
14. Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.
Rowe AM; Yun H; Treat BR; Kinchington PR; Hendricks RL
J Immunol; 2017 Feb; 198(4):1706-1717. PubMed ID: 28062697
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
Schmidt A; Éliás S; Joshi RN; Tegnér J
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
[TBL] [Abstract][Full Text] [Related]
16. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
17. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
[TBL] [Abstract][Full Text] [Related]
18. Cornea-infiltrating and lymph node dendritic cells contribute to CD4+ T cell expansion after herpes simplex virus-1 ocular infection.
Buela KA; Hendricks RL
J Immunol; 2015 Jan; 194(1):379-87. PubMed ID: 25422507
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-Derived Suppressor Cells Confer Infectious Tolerance to Dampen Virus-Induced Tissue Immunoinflammation.
Sarkar R; Mathew A; Sehrawat S
J Immunol; 2019 Sep; 203(5):1325-1337. PubMed ID: 31331972
[TBL] [Abstract][Full Text] [Related]
20. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
